Addendum: LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair.

Zhou, Jianli; Sturtevant, Drew; Love, Cassie; Kulkarni, Aditya; Biyani, Neha; Kathad, Umesh; Thacker, Elizabeth; Dave, Sandeep; Bhatia, Kishor

Zhou, Jianli; Sturtevant, Drew; Love, Cassie; Kulkarni, Aditya; Biyani, Neha; Kathad, Umesh; Thacker, Elizabeth; Dave, Sandeep; Bhatia, Kishor.

Afiliación

Zhou J; Lantern Pharma Inc., Plano, TX 75024, USA.
Sturtevant D; Lantern Pharma Inc., Plano, TX 75024, USA.
Love C; Department of Medicine, Duke University, Durham, NC 27708, USA.
Kulkarni A; Lantern Pharma Inc., Plano, TX 75024, USA.
Biyani N; Lantern Pharma Inc., Plano, TX 75024, USA.
Kathad U; Lantern Pharma Inc., Plano, TX 75024, USA.
Thacker E; Data Driven Bioscience, Durham, NC 27707, USA.
Dave S; Department of Medicine, Duke University, Durham, NC 27708, USA.
Bhatia K; Lantern Pharma Inc., Plano, TX 75024, USA.

Oncotarget ; 14: 722, 2023 Jul 20.

Article en En | MEDLINE | ID: mdl-37477520

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google